The subject of this public procurement contract is the delivery and installation of a fully functional set of devices for whole genome, whole transcriptome, and amplicon sequencing of suspension cell samples and solid tissue sections from the level of one cell upwards. This system will be intended for performing highly accurate nucleic acid sequencing and for conducting advanced transcriptomic analyses at the single-cell level directly from tissue sections. The set will be used to address a wide range of innovative research tasks undertaken in international research consortia, with a translation into new standardized diagnostic methods (according to Article 5 (5) of EU Regulation 2017/746), monitoring minimal residual disease in acute leukemias, including the analysis of genetic changes in tumor cells, identification of mutations associated with disease progression with high accuracy, and detailed descriptions of genomic characteristics of tumor and immune cells of patients for the needs of the Scientific and Diagnostic Oncology Center FN Motol. The offered devices must meet the technical requirements for the subject of performance set by the contracting authority, to the extent specified in Annex no. 1 of the purchase contract – Technical specification of the subject of performance. The subject of performance furthermore includes post-warranty service of the devices. The contractual relationship between the contracting authority and the supplier will be governed by the Service Provision Agreement, which will be concluded with the selected supplier after demonstrating fulfillment of all conditions required by the contracting authority.

LOT-0001
Equipment of the Scientific and Diagnostic Oncology Center – Motol University Hospital, Prague – systems for whole-transcriptome sequencing.
The subject of this public procurement contract is the delivery and installation of a fully functional set of devices for whole genome, whole transcriptome, and amplicon sequencing of suspension cell samples and solid tissue sections from the level of one cell upwards. This system will be intended for performing highly accurate nucleic acid sequencing and for conducting advanced transcriptomic analyses at the single-cell level directly from tissue sections. The set will be used to address a wide range of innovative research tasks undertaken in international research consortia, with a translation into new standardized diagnostic methods (according to Article 5 (5) of EU Regulation 2017/746), monitoring minimal residual disease in acute leukemias, including the analysis of genetic changes in tumor cells, identification of mutations associated with disease progression with high accuracy, and detailed descriptions of genomic characteristics of tumor and immune cells of patients for the needs of the Scientific and Diagnostic Oncology Center FN Motol. The offered devices must meet the technical requirements for the subject of performance set by the contracting authority, to the extent specified in Annex no. 1 of the purchase contract – Technical specification of the subject of performance. The subject of performance furthermore includes post-warranty service of the devices. The contractual relationship between the contracting authority and the supplier will be governed by the Service Provision Agreement, which will be concluded with the selected supplier after demonstrating fulfillment of all conditions required by the contracting authority.